03 Feb 2025
// PRESS RELEASE
11 Dec 2024
// PRESS RELEASE
17 Jul 2024
// PR NEWSWIRE
SPI Pharma has been solving formulation challenges using superior functional materials.
About
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Booth #E3D40
24-26 June, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Booth #E3D40
24-26 June, 2025
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
03 Feb 2025
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/enhancing-patient-experience-with-ultraburst-the-ultimate-odt-solution/
11 Dec 2024
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/beyond-pharma-spi-pharma-s-impact-across-industries/
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/spi-pharma-inc-and-inimmune-corp-partner-to-develop-and-commercialize-innovative-vaccine-adjuvant-systems-302198093.html
08 Jan 2024
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/embracing-patient-centric-formulations-for-a-healthier-tomorrow/
13 Oct 2023
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/offering-broader-access-to-sustainable-and-scalable-pharma-grade-saponin-adjuvants/
10 Jul 2023
// EXCIPACT
https://www.excipact.org/news-reader/spi-pharma-in-grand-haven-usa-receives-excipact-gmp-certification-as-pharmaceutical-excipient-supplier.html
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39418
Submission : 2024-03-06
Status : Active
Type : II
Certificate Number : R1-CEP 2008-190 - Rev 00
Issue Date : 2014-10-07
Type : Chemical
Substance Number : 39
Status : Valid
NDC Package Code : 12784-459
Start Marketing Date : 2022-09-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
Certificate Number : R1-CEP 2008-264 - Rev 00
Issue Date : 2014-11-17
Type : Chemical
Substance Number : 311
Status : Valid
Certificate Number : R1-CEP 2008-270 - Rev 00
Issue Date : 2014-11-18
Type : Chemical
Substance Number : 311
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39027
Submission : 2024-06-14
Status : Active
Type : II
NDC Package Code : 58103-143
Start Marketing Date : 2023-11-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (90kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
Certificate Number : R0-CEP 2022-054 - Rev 00
Issue Date : 2023-02-10
Type : Chemical
Substance Number : 39
Status : Valid
NDC Package Code : 12784-458
Start Marketing Date : 2022-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
NDC Package Code : 58103-141
Start Marketing Date : 2023-08-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (77.5kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
NDC Package Code : 58103-142
Start Marketing Date : 2023-08-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (77.5kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
NDC Package Code : 12784-460
Start Marketing Date : 2023-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
NDC Package Code : 12784-461
Start Marketing Date : 2023-08-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5.9kg/100kg 1.1kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
NDC Package Code : 12784-460
Start Marketing Date : 2024-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PRO...
Excipients
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21367
Submission : 2008-02-27
Status : Active
Type : II
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17044
Submission : 2003-12-22
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24099
Submission : 2010-08-27
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28402
Submission : 2014-06-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16037
Submission : 2002-07-03
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20389
Submission : 2007-03-30
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37133
Submission : 2022-08-17
Status : Active
Type : IV
Excipients Web Link
Excipients by Ingredients
Excipients By applications
Inspections and registrations
ABOUT THIS PAGE
SPI Pharma is a supplier offers 10 products (APIs, Excipients or Intermediates).
Find a price of Magnesium Hydroxide bulk with DMF, CEP offered by SPI Pharma
Find a price of Aluminum bulk with CEP offered by SPI Pharma
Find a price of Calcium Carbonate bulk with DMF offered by SPI Pharma
Find a price of Magnesium Hydroxide bulk with CEP offered by SPI Pharma
Find a price of Aluminium Hydroxide bulk offered by SPI Pharma
Find a price of Calcium Carbonate bulk offered by SPI Pharma
Find a price of Magaldrate bulk offered by SPI Pharma
Find a price of Magnesium Carbonate bulk offered by SPI Pharma
Find a price of Magnesium Hydroxide bulk offered by SPI Pharma
Find a price of Paracetamol bulk offered by SPI Pharma